We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Swartz, MH. The breast. In: Textbook of Physical Diagnosis, 7th edition. Philadelphia: Saunders, 2014: 409–438.Google Scholar
7
Gadd, MA. Screening for breast cancer. In: Cameron, JL, Cameron, AM (eds). Current Surgical Therapy: Expert Consult, 11th edition. Philadelphia: Saunders, 2014: 568–571.Google Scholar
8
ACOG. Breast cancer screening. Practice Bulletin 122. August 2011.Google Scholar
9
Nelson, AL. Controversies regarding mammography, breast self-examination and clinical breast examination. Obstet Gynecol Clin N Am2013; 40(3):413–427.CrossRefGoogle ScholarPubMed
10
Gotzsche, PC, Jorgensen, KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev2013 Jun 4;6:CD001877.Google Scholar
11
Grube, BJ, Giuliano, AE. Benign breast disease. In: Berek, JS (ed). Berek and Novak’s Gynecology, 14th edition. Philadelphia: Lippincott Williams & Wilkins, 2007: 637–668.Google Scholar
Winchester, DP, Sener, S, Immerman, S, Blum, M. A systematic approach to the evaluation and management of breast masses. Cancer1983 June 15; 51:2535–2539.3.0.CO;2-C>CrossRefGoogle Scholar
14
Green, VL. Breast cancer risk assessment, prevention, and the future. Obstet Gynecol Clin N Am2013; 40:525–529.CrossRefGoogle ScholarPubMed
15
Vargas, HI, Vargas, MP, Eldrageely, K, et al. Outcomes of surgical and sonographic assessment of breast masses in women younger than 30. Am Surg2005 Sep;71(9):716–719.CrossRefGoogle ScholarPubMed
16
Fallat, ME, Ignacio, RC. Breast disorders in children and adolescents. J Pediatr Adolesc Gynecol2008;21:311–316.CrossRefGoogle ScholarPubMed
17
Bassett, LW, Jackson, VP, Fu, KL, Fu, YS. Diagnosis of Diseases of the Breast, 2nd edition. St. Louis: WB Saunders, 1997: 424.Google Scholar
18
Smallwood, JA, Roberts, A, Guyer, PD, Taylor, I. The natural history of fibroadenoma. Br J Clinic Prac1988;56(Suppl):86–87.Google Scholar
19
Kaufman, CS, Littrup, PJ, Freeman-Gibb, LA, et al. Office-based cryoablation of breast fibroadenomas with long-term follow-up. Breast Journal2005;11(5):344–350.CrossRefGoogle ScholarPubMed
20
Onstad, M, Stuckey, A. Benign breast disorders. Obstet Gynecol Clin N Am2013 Sep;40(3):459–473.CrossRefGoogle ScholarPubMed
21
Chang, HL, Lerwill, MF, Goldstein, AM. Breast hamartomas in adolescent females. Breast Journal2009;15(5):515–520.CrossRefGoogle ScholarPubMed
22
Morrogh, M, Park, A, Elkin, EB, King, TA. Lessons learned from 416 cases of nipple discharge of the breast. Am Journ of Surg2010;200:73–80.CrossRefGoogle ScholarPubMed
Moriarity, AT, Schwartz, MR, Laucirica, R, et al. Cytology of spontaneous nipple discharge: Is it worth it?Arch Pathol Lab Med2013 Aug;137(8):1039–1042.Google Scholar
25
Dolan, RT, Butler, JS, Kell, MR, et al. Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk. The Surgeon2010;8(5):252–258.CrossRefGoogle ScholarPubMed
26
Sickles, EA. Galactography and other imaging investigations of nipple discharge. Lancet2000;356:1622–1623.CrossRefGoogle ScholarPubMed
27
Paterok, EM, Rosenthal, H, Sabel, M. Nipple discharge and abnormal galactogram: results of a long-term study (1964–1990). European Jour of Obstet & Gynecol & Reproduce boil1993;50:227–234.CrossRefGoogle ScholarPubMed
28
Orel, SG, Dougherty, CS, Reynolds, C, et al. MRI imaging in patients with nipple discharge: initial experience. Radiology2000;216(1):248–254.CrossRefGoogle ScholarPubMed
29
Rahal, RM, de Freitas-Júnior, R, Carlos da Cunha, L, et al. Mammary duct ectasia: an overview. Breast J2011 Nov–Dec;17(6):694–695.CrossRefGoogle ScholarPubMed
30
Al Sarakbi, W, Worku, D, Escobar, PF, Mokbel, K. Breast papillomas: current management with a focus on a new diagnostic and therapeutic modality. Int Semin Surg Oncol2006;3(1):1.CrossRefGoogle ScholarPubMed
31
Dixon, JM, Khan, LR. Treatment of breast infections. BMJ2011;342:d396.CrossRefGoogle Scholar
32
Ocal, K, Dag, A, Turkmenoglu, O, et al. Granulomatous mastitis: clinical, pathological features and management. Breast J2010 Mar–Apr;16(2):176–182.CrossRefGoogle ScholarPubMed
33
Boutet, G. Breast inflammation: clinical examination, aetiological pointer. Diagnostic and Interventional Imaging2012;93:78–84.CrossRefGoogle Scholar
34
National Program of Cancer Registries. US cancer stats; 1999–2007. Cancer incidence and mortality data. www.nccd.cdc.gov. Accessed April 2014.Google Scholar
35
Euhus, DM. Breast disease, In: Hoffman, BL, Schorge, JO, Schaffer, JI, et al. (eds). Williams Gynecology, 2nd edition. New York: McGraw-Hill, 2012:333–355.Google Scholar
36
Salzman, B, Fleegle, S, Tully, A. Common breast problems. Am Fam Physicians2012;86(4):343–349.Google ScholarPubMed
37
Leung, JW, Kornguth, PJ, Gollway, MB. Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med2002;21(5):521–526.CrossRefGoogle ScholarPubMed
38
Srivastava, A, Mansel, RE, Arvind, N, et al. Evidence-based management of mastalgia: a metaanalysis of RCTs. Breast2007;16:503–512.CrossRefGoogle Scholar
39
Euhus, DM, Uyehara, C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women; a multi-institutional cross-sectional study. J AM Coll Surg1997;184(6):596.Google ScholarPubMed
40
Fentiman, IS, Caleffi, M, Hamed, H, Chaudary, MA. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg1988;75(9):845–846.CrossRefGoogle ScholarPubMed
41
O’Brien, PM, Abukhalil, IE. RCT of the management of PMS and premenstrual mastalgia using luteal phase only danazol. Am J Obstet Gynecol1999;180:18–23.CrossRefGoogle Scholar
42
Mansel, RE, Preece, PE, Hughes, LE. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast. Br J Surg1978;65(10):724–727.CrossRefGoogle ScholarPubMed
43
Mansel, RE, Goyal, A, Preece, P, et al. European randomized, multicentre study of goesrelin (zoladex) in the management of mastalgia. Am J Obstet Gynecol2004;191(6):1942–1949.CrossRefGoogle ScholarPubMed
References
1
Nicolle, LE. Epidemiology of urinary tract infections. Infect Med2001; 18:153–62.Google Scholar
Sammon, JD, Sharma, P, Rahbar, H, et al. Predictors of admission in patients presenting to the emergency department with urinary tract infection. World J Urol2014; 32:813–9.CrossRefGoogle Scholar
4
Nicolle, LE, Bradley, S, Colgan, R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis2005; 40(5):643–54.CrossRefGoogle Scholar
5
Barber, AE, Norton, JP, Spivak, AM, et al. Urinary tract infections: current and emerging management strategies. Clin Infect Dis2013; 57(5):719–24.CrossRefGoogle ScholarPubMed
Fowler, JE, Stamey, TA. Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence. J Urol1977; 117:472–6.CrossRefGoogle ScholarPubMed
11
Mulvey, MA, Lopez-Boado, YS, Wilson, CL, et al. Induction and evasion of host defences by type 1-piliated uropathogenic Escherichia coli. Science1998; 282:1494–7.CrossRefGoogle ScholarPubMed
12
Anderson, GG, Palermo, JJ, Schilling, JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science2003; 301:105–7.CrossRefGoogle ScholarPubMed
13
Johnson, JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am2003; 17:261–78.CrossRefGoogle ScholarPubMed
14
Holmgren, K. Urinary calculi and urinary tract infection: a clinical and microbiological study. Scand J Urol Nephrol Suppl1986; 98:1–71.Google ScholarPubMed
15
Foxman, B, Gillespie, B, Koopman, J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol2000; 151:1194–1205.CrossRefGoogle ScholarPubMed
16
Foxman, B, Barlow, R, d’Arcy, H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol2000; 10:509–15.CrossRefGoogle ScholarPubMed
17
Sheinfeld, J, Schaeffer, AJ, Cordon-Cardo, C, et al. Association of the Lewis blood group phenotype with recurrent urinary tract infections in women. N Engl J Med1989; 320:773–7.CrossRefGoogle ScholarPubMed
18
Twaij, M. Urinary tract infection in children: a review of its pathogenesis and risk factors. J R Soc Health2000; 120:220–6.CrossRefGoogle ScholarPubMed
19
Scholes, D, Hooton, TM, Roberts, DL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis2000; 182:1177–82.CrossRefGoogle ScholarPubMed
20
Hooton, TM, Fennell, CL, Clark, AM, Stamm, WE. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. J Infect Dis1991; 164(6):1216–19.CrossRefGoogle ScholarPubMed
21
Hooton, TM, Scholes, D, Hughes, JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. New Eng J Med1996; 335:468–74.CrossRefGoogle ScholarPubMed
22
Hooton, TM, Hillier, S, Johnson, C, et al. Escherichia coli bacteriuria and contraceptive method. JAMA1991; 265:64–9.CrossRefGoogle ScholarPubMed
23
Foxman, B, Marsh, J, Gillespie, B, et al. Condom use and first-time urinary tract infection. Epidemiology1997; 8:637–41.CrossRefGoogle ScholarPubMed
24
Stamm, WE, Hooton, TM. Management of urinary tract infections in adults. N Engl J Med1993; 329:1328–34.Google ScholarPubMed
25
Bent, S, Saint, S. The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Dis Mon2003; 49:83–98.CrossRefGoogle ScholarPubMed
26
Lifshitz, E, Kramer, L. Outpatient urine collection: does collection technique matter?Arch Intern Med2000; 160:2537–40.CrossRefGoogle ScholarPubMed
27
Stamm, WE. Measurement of pyuria and its relation to bacteriuria. Am J Med1983; 75:53–8.CrossRefGoogle ScholarPubMed
28
Hurlbut, TAIII, Littenberg, B. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol1991; 96:582–8.CrossRefGoogle ScholarPubMed
29
Hooton, TM, Stamm, WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am1997; 11:551–81.CrossRefGoogle ScholarPubMed
30
Nosseir, SB, Lind, LR, Winkler, HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health2012; 21(3):347–54.CrossRefGoogle ScholarPubMed
31
Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society of Microbiology and Infectious Diseases. Clin Infect Dis2011; 52:e103–20.CrossRefGoogle Scholar
32
Franco, AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol2005; 19(6):861–73.CrossRefGoogle ScholarPubMed
33
Nicolle, LE. A practical guide to antimicrobial management of complicated urinary tract infection. Drugs & Aging2001; 18(4):243–54.CrossRefGoogle ScholarPubMed
34
Browne, RFJ, Zwirewich, C, Torreggiani, WC. Imaging of urinary tract infection in the adult. Eur Radiol2004; 14:E168–83.Google ScholarPubMed
35
Berg, AO, Heidrich, FE, Fihn, SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice: comparison of clinical examination and comprehensive microbiology. JAMA1984; 251:620–5.CrossRefGoogle Scholar
36
Bent, S, Saint, S. The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med2002; 113(1A):20S–28S.CrossRefGoogle ScholarPubMed
37
Schmiemann, G, Kniehl, E, Gebhardt, K, et al. The diagnosis of urinary tract infection, a systematic review. Dtsch Arztebl Int2010; 107(21):361–7.Google ScholarPubMed
38
Nicolle, LE, Ronald, AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am1987; 1:793–806.CrossRefGoogle ScholarPubMed
39
Ronald, AR, Conway, B. An approach to urinary tract infections in ambulatory women. Curr Clin Top Infect Dis1988; 9:76–125.Google ScholarPubMed
40
McLaughlin, SP, Carson, CC. Urinary tract infections in women. Med Clin North Am2004; 88:417–429.CrossRefGoogle ScholarPubMed
41
Albert, X, Huertas, I, Pereiro, II, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev2004; 3:CD001209.Google Scholar
42
Melekos, MD, Asbach, HW, Gerharz, E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol1997; 157:935–9.CrossRefGoogle ScholarPubMed
43
Chew, LD, Fihn, SD. Recurrent cystitis in nonpregnant women. West J Med1999; 170:274–7.Google ScholarPubMed
44
Stapleton, A, Latham, RH, Johnson, C, Stamm, WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection: a randomized, double-blind, placebo-controlled trail. JAMA1990; 264:703–6.CrossRefGoogle Scholar
Stapleton, A. Novel approaches to prevention of urinary tract infections. Infect Dis Clin North Am2003; 17:457–71.CrossRefGoogle ScholarPubMed
47
Gratacos, E, Torres, PJ, Vila, J, et al. Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Infect Dis1994; 169:1390–2.CrossRefGoogle ScholarPubMed
48
Kincaid-Smith, P, Bullen, M. Bacteriuria in pregnancy. Lancet1965; 191:395–9.Google Scholar
49
Smaill, F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev2001; 2:CD000490.Google Scholar
50
Mittendorf, R., Williams, MA, Kass, EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis1992; 14:927–32.CrossRefGoogle ScholarPubMed
51
Vogel, T, Verreault, R, Gourdeau, M, et al. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ2004; 170(4):469–73.Google ScholarPubMed
References
1
Steiner, M, McDougall, M, Brown, E. The premenstrual symptoms screening tool for clinicians. Arch Womens Mental Health. 2003; 6:203–209.CrossRefGoogle ScholarPubMed
2
Endicott, J, Amsterdam, J, Eriksson, E, et al. Is premenstrual dysphoric disorder a distinct clinical entity?J Womens Health Gender-Based Med.1999; 8:663–679.CrossRefGoogle ScholarPubMed
3
Condone, JT. The premenstrual syndrome: a twin study. Br J Psychiatry. 1993; 162:481–486.CrossRefGoogle Scholar
4
Schmidt, PJ, Nieman, LK, Danaceau, MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. Am J Obstet Gynecol.1990; 162:99–105.Google Scholar
5
Casson, P, Hahn, PM, Van Vugt, DA. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol.1991; 162:99–105.CrossRefGoogle Scholar
6
Klatzkin, R, Bunevicius, A, Fomeris, C, Girdler, S. Menstrual mood disorders are associated with blunted sympathetic reactivity to stress. J Psychosom Res.2014 Jan; 76(1):46–55.CrossRefGoogle ScholarPubMed
7
Case, AM, Reid, RL. Menstrual cycle effects on common medical conditions. Compr Ther.2001; 27:65.CrossRefGoogle ScholarPubMed
8
Altman, G, Cain, KC, Motzer, S, et al. Increased symptoms in female IBS patients with dysmennorhea and PMS. Gastroenterol Nurs.2006; 29:4.CrossRefGoogle Scholar
9
Roca, CA, Schmidt, PJ, Bloch, M, et al. Implications of endocrine studies of premenstrual syndrome. Psychiatr Ann.1996; 26:576–580.CrossRefGoogle Scholar
10
Rapkin, AJ, Edelmuth, E, Chang, LC, et al. Whole blood serotonin in premenstrual syndrome. Obstet Gynecol.1987; 70:533–537.Google ScholarPubMed
11
Taylor, DL, Mathew, RJ, Ho, BT, et al. Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiology. 1984; 12:16–18.CrossRefGoogle ScholarPubMed
Albreich, U, Petty, F, Yonkers, K, et al. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry. 1996; 153:718–720.Google Scholar
14
Rapkin, AJ, Shouple, D, Reading, A, et al. Decreased central opioid activity in premenstrual syndrome: leutenizing hormone response to naloxone. J Soc Gynecol Investig.1996; 3:93–96.Google Scholar
15
Chuong, CJ, Coulam, CB, Bergstralh, EJ, et al. Clinical trial of naltrexone in premenstrual syndrome. Obstet Gynecol.1988; 72:332–336.Google ScholarPubMed
16
Rapkin, AJ, Morgan, M, Goldman, L, et al. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol.1997; 90:709.CrossRefGoogle ScholarPubMed
17
Guidotti, A, Costa, E. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allpregnenolone) availability?Biol Psych.1998; 44:865–873.CrossRefGoogle ScholarPubMed
18
Wikander, I, Sundblad, C, Andersch, B, et al. Citalopram in premenstrual dysporia: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?J Clin Psychopharmacol.1998; 18S:390–398.CrossRefGoogle Scholar
19
Freeman, EW, Sonheimer, SJ, Rickels, K. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull. 1997; 33:303–309.Google ScholarPubMed
20
Halbreich, U, Rojansky, N, Palter, S. Elimination of ovulation and menstrual cyclicity (with Danazol) improves dysphoric menstrual syndromes. Fert Steril. 1991; 56:1066–1069.CrossRefGoogle Scholar
21
Bancroft, J, Rennie, D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res.1993; 37:195–202.CrossRefGoogle ScholarPubMed
22
Wyatt, K, Dimmock, P, Jones, P, et al. Efficacy of progesterone and progestogens in management of premenstrual syndrome: a systematic review. BMJ.2001; 323:134.CrossRefGoogle Scholar
23
Yonkers, KA, Brown, C, Pearlstein, TB, et al. Efficacy of a new low dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol.2005; 106:492.CrossRefGoogle ScholarPubMed
24
Thys-Jacobs, S, Starkey, P, Bernstein, D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol.1998; 179:444–452.CrossRefGoogle ScholarPubMed
25
Walker, AF, De Souza, MC, Vicker, MF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998; 7:1157–1165.CrossRefGoogle ScholarPubMed
26
Stevenson, C, Ernest, E. Complementary/alternative therapies for premenstrual syndrome: asystematic review of randomized controlled trials. Am J Obstet Gynecol.2001; 185:227.CrossRefGoogle Scholar
27
Schellenberg, R. Treatment for premenstrual syndrome with angus castus fruit extract: prospective randomized placebo-controlled study. BMJ.2001; 322:134.CrossRefGoogle Scholar
28
Blake, F, Salkovskis, P, Gath, D, et al. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res.1998; 45:307.CrossRefGoogle ScholarPubMed
Evidence-based references
Douglas, S. Premenstrual syndrome: evidence-based treatment in family practice. Can Fam Physician.2002; 48:1789.Google ScholarPubMed
Rapkin, AJ. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology. 2003 Aug; 28(Suppl 3):39–53.CrossRefGoogle ScholarPubMed
Cunningham, J, Yonkers, K, O’Brien, S, Eriksson, E. Update on research and treatment of premenstrual dysphoric disorder; Harv Rev Psychiatry. 2009; 17(2):120–137.CrossRefGoogle ScholarPubMed
References
1
Kessler, RC. Epidemiology of women and depression. J Affect Disord.2003 Mar;74(1):5–13.CrossRefGoogle ScholarPubMed
2
Kessler, RC, McGonagle, KA, Zhao, S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry.1994 Jan;51(1):8–19.CrossRefGoogle ScholarPubMed
3
Gavin, NI, Gaynes, BN, Lohr, KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol.2005 Nov;106(5 Pt 1):1071–83.CrossRefGoogle ScholarPubMed
4
Cohen, LS, Soares, CN, Vitonis, AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry.2006 Apr;63(4):385–90.CrossRefGoogle Scholar
5
Scholle, SH, Kelleher, K. Assessing primary care performance in an obstetrics/gynecology clinic. Women Health.2003;37(1):15–30.CrossRefGoogle Scholar
6
Scholle, SH, Chang, JC, Harman, J, McNeil, M. Trends in women’s health services by type of physician seen: data from the 1985 and 1997–98 NAMCS. Womens Health Issues.2002 Aug;12(4):165–77.CrossRefGoogle ScholarPubMed
7
Spitzer, RL, Williams, JB, Kroenke, K, et al. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol.2000 Sep;183(3):759–69.CrossRefGoogle Scholar
8
Smith, MV, Rosenheck, RA, Cavaleri, MA, et al. Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinics. Psychiatr Serv.2004 Apr;55(4):407–14.CrossRefGoogle ScholarPubMed
9
Blumenthal, SJ, Kupfer, DJ, eds. Suicide over the Life Cycle: Risk Factors, Assessment, and Treatment of Suicidal Patients. Washington, DC: American Psychiatric Association; 1990.Google Scholar
10
Chisholm, D. The economic costs of depression. In: Dawson, A, Tylee, A, eds. Depression: Social and Economic Timebomb. London: BMJ Books; 2001.Google Scholar
11
Murray, CJ, Lopez, AD. Evidence-based health policy – lessons from the Global Burden of Disease Study. Science.1996;274(5288):740–3.CrossRefGoogle ScholarPubMed
12
Rucker, L, Frye, EB, Cygan, RW. Feasibility and usefulness of depression screening in medical outpatients. Arch Intern Med.1986 Apr;146(4):729–31.CrossRefGoogle ScholarPubMed
13
Zung, WW. The role of rating scales in the identification and management of the depressed patient in the primary care setting. J Clin Psychiatry. 1990 Jun;51(Suppl):72–6.Google ScholarPubMed
14
Schade, CP, Jones, ER, Wittlin, BJ. A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv.1998 Jan;49(1):55–61.CrossRefGoogle ScholarPubMed
15
O’Connor, EA, Whitlock, EP, Gaynes, B, Beil, TL. Screening for Depression in Adults and Older Adults in Primary Care: An Updated Systematic Review [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); 2009 [cited 2014 Aug 29]. Available from: www.ncbi.nlm.nih.gov/books/NBK36403. Accessed 12 Dec 2015.Google Scholar
16
US Preventive Services Task Force. Screening for depression in adults: summary of the evidence. Ann Intern Med.2002;136:765–76.Google Scholar
17
Mitchell, AJ, Coyne, JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract.2007 Feb;57(535):144–51.Google ScholarPubMed
18
Arroll, B, Khin, N, Kerse, N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ.2003 Nov 15;327(7424):1144–6.CrossRefGoogle ScholarPubMed
19
Whooley, MA, Avins, AL, Miranda, J, Browner, WS. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med.1997 Jul;12(7):439–45.CrossRefGoogle ScholarPubMed
20
Richardson, LP, Rockhill, C, Russo, JE, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics.2010 May;125(5):e1097–1103.CrossRefGoogle ScholarPubMed
21
Nease, DEJr, Maloin, JM. Depression screening: a practical strategy. J Fam Pract.2003;52(2):118–24.Google ScholarPubMed
22
Kirmayer, LJ, Robbins, JM, Dworkind, M, Yaffe, MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry.1993 May;150(5):734–41.Google ScholarPubMed
23
Mueller, TI, Leon, AC, Keller, MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry.1999 Jul;156(7):1000–6.CrossRefGoogle ScholarPubMed
24
Keller, MB, Lavori, PW, Rice, J, et al. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry.1986 Jan;143(1):24–8.Google ScholarPubMed
25
Ford, DE, Mead, LA, Chang, PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med.1998 Jul 13;158(13):1422–6.CrossRefGoogle ScholarPubMed
26
Ciechanowski, PS, Katon, WJ, Russo, JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med.2000;160(21):3278–85.CrossRefGoogle ScholarPubMed
27
Robinson, RG, Bolduc, PL, Price, TR. Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke.1987;18(5):837–43.CrossRefGoogle ScholarPubMed
28
Taylor, CB, Youngblood, ME, Catellier, D, et al.; ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry.2005;62(7):792–8.CrossRefGoogle ScholarPubMed
29
Rihmer, Z, Dome, P, Gonda, X. The role of general practitioners in prevention of depression-related suicides. Neuropsychopharmacol Hung.2012 Dec;14(4):245–51.Google ScholarPubMed
30
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text revision. Washington, DC: American Psychiatric Association; 2013.Google Scholar
31
LaRocco-Cockburn, A, Melville, J, Bell, M, Katon, W. Depression screening attitudes and practices among obstetrician-gynecologists. Obstet Gynecol.2003 May;101(5 Pt 1):892–8.CrossRefGoogle ScholarPubMed
32
Kelly, R, Zatzick, D, Anders, T. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. Am J Psychiatry.2001 Feb;158(2):213–19.CrossRefGoogle ScholarPubMed
33
Cuijpers, P, Dekker, J, Hollon, SD, Andersson, G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry.2009 Sep;70(9):1219–29.CrossRefGoogle ScholarPubMed
34
Arroll, B, Macgillivray, S, Ogston, S, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med.2005;3(5):449–56.CrossRefGoogle ScholarPubMed
35
Trivedi, MH, Rush, AJ, Wisniewski, SR, et al.; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry.2006;163(1):28–40.CrossRefGoogle Scholar
36
American Psychiatric Association: Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd ed. Washington, DC: American Psychiatric Association; 2010.Google Scholar
37
Quitkin, FM, Petkova, E, McGrath, PJ, et al. When should a trial of fluoxetine for major depression be declared failed?Am J Psychiatry. 2003 Apr;160(4):734–40.CrossRefGoogle ScholarPubMed
38
Posternak, MA, Baer, L, Nierenberg, AA, Fava, M. Response rates to fluoxetine in subjects who initially show no improvement. J Clin Psychiatry.2011 Jul;72(7):949–54.CrossRefGoogle ScholarPubMed
39
Hu, XH, Bull, SA, Hunkeler, EM, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry.2004 Jul;65(7):959–65.CrossRefGoogle ScholarPubMed
40
Nierenberg, AA, Fava, M, Trivedi, MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006 Sep;163(9):1519–30; quiz 1665.CrossRefGoogle Scholar
41
Clayton, AH, Gillespie, EH. Bupropion. In: Schatzberg, AF, Nemeroff, CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology, 4th ed. Washington, DC: American Psychiatric Publishing, Inc.; 2009.Google Scholar
42
Montgomery, SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol.1995 Dec;10(Suppl 4):37–45.CrossRefGoogle ScholarPubMed
43
Parikh, SV, Segal, ZV, Grigoriadis, S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord.2009 Oct;117(Suppl 1):S15–25.CrossRefGoogle ScholarPubMed
44
Churchill, R, Moore, THM, Furukawa, TA, et al. “Third wave” cognitive and behavioural therapies versus treatment as usual for depression. Cochrane Database Syst Rev.2013;10:CD008705.Google Scholar
45
Cuijpers, P, Geraedts, AS, van Oppen, P, et al. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychiatry.2011 Jun;168(6):581–92.CrossRefGoogle ScholarPubMed
46
Cooney, GM, Dwan, K, Greig, CA, et al. Exercise for depression. Cochrane Database Syst Rev.2013;9:CD004366.Google Scholar
47
Chalder, M, Wiles, NJ, Campbell, J, et al. Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ.2012;344:e2758.CrossRefGoogle ScholarPubMed
48
Jorm, AF, Morgan, AJ, Hetrick, SE. Relaxation for depression. Cochrane Database Syst Rev.2008;4:CD007142.Google Scholar
49
Steege, JF, Blumenthal, JA. The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. J Psychosom Res.1993;37(2):127–33.CrossRefGoogle ScholarPubMed
50
Aganoff, JA, Boyle, GJ. Aerobic exercise, mood states and menstrual cycle symptoms. J Psychosom Res.1994 Apr;38(3):183–92.CrossRefGoogle ScholarPubMed
51
Goodale, IL, Domar, AD, Benson, H. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol.1990 Apr;75(4):649–55.Google ScholarPubMed
52
Stone, AB, Pearlstein, TB, Brown, WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry.1991 Jul;52(7):290–3.Google ScholarPubMed
53
Wood, SH, Mortola, JF, Chan, YF, et al. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol.1992 Sep;80(3 Pt 1):339–44.Google ScholarPubMed
54
Shah, NR, Jones, JB, Aperi, J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol.2008 May;111(5):1175–82.CrossRefGoogle ScholarPubMed
55
Beck, CT. Predictors of postpartum depression: an update. Nurs Res.2001 Oct;50(5):275–85.CrossRefGoogle ScholarPubMed
Simon, RI. Psychiatry and Law for Clinicians. Washington, DC: American Psychiatric Press; 1992.Google Scholar
58
Swartz, M. Malpractice liability for suicide. Clinical, legal, and rhetorical dimensions. Psychiatric Forum.1988;14(1):45–53.Google Scholar
References
1
Kreipe, RE, Birndorf, SA. Eating disorders in adolescents and young adults. Med Clin North Am2000; 84:1027–49.CrossRefGoogle ScholarPubMed
2
Becker, AE, Grinspoon, SK, Klibanski, A, Herzog, DB. Eating disorders. N Engl J Med1999; 340:1092–8.CrossRefGoogle ScholarPubMed
3
Linna, MS, Raevuori, A, Haukka, J, et al. Reproductive health outcomes in eating disorders. Int J Eat Disord2013; 46(8):826–33.CrossRefGoogle ScholarPubMed
4
Herzog, DB, Nussbaum, KM, Marmor, AK. Comorbidity and outcome in eating disorders. Psychiatr Clin North Am1996; 19:843–59.CrossRefGoogle ScholarPubMed
5
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition.Washington, DC: American Psychiatric Association; 2013: 329–54.Google Scholar
6
Mitchell, AM, Bulik, CM. Eating disorders and women’s health: an update. J Midwifery Women’s Health2006; 51(3):193.CrossRefGoogle ScholarPubMed
7
Hoek, HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry2006; 19(4):389.CrossRefGoogle ScholarPubMed
8
Pearlstein, T. Eating disorders and comorbidity. Arch Womens Ment Health2002; 4:67–78.CrossRefGoogle Scholar
9
Fisher, M. The course and outcome of eating disorders in adults and adolescents: a review. Adolesc Med2003; 14(1):149–58.Google ScholarPubMed
10
Allen, KL, Bryne, SM, Oddy, WH, et al. DSM-IV-TR and DSM-5 eating disorders in adolescents: prevalence, stability, and psychological correlates in a population-based sample of male and female adolescents. J Abnorm Psychol2013; 122(3):720–32.CrossRefGoogle Scholar
11
Swanson, SA, Crow, SJ, Le Grange, DL, et al. Prevalence and Correlates of Eating Disorders in Adolescents. Arch Gen Psychiatry2011 July; 68(7):714–23. doi:10.1001/archgenpsychiatry.2011.22. Epub 2011 Mar 7.CrossRefGoogle ScholarPubMed
12
Javaras, KN, Laird, NM, Reichborn-Kjennerud, T, et al. Familiality and heritability of binge eating disorder: results of a case–control family study and a twin study. Int J Eat Disord2008; 41:174–9.CrossRefGoogle Scholar
13
Bulik, CM, Slof-Op’t Landt, MC, van Furth, EF. The genetics of anorexia nervosa. Ann Rev Nutr2007; 27:263–75.CrossRefGoogle ScholarPubMed
Bulik, CM, Devlin, B, Bacanu, SA, et al. Significant linkage on chromosome 10p in families with bulimia nervosa. Am J Hum Genet2003; 72(1):200–7.CrossRefGoogle ScholarPubMed
16
Grice, DE, Halmi, KA, Fichter, MM, et al. Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet2002; 70(3):787–92.CrossRefGoogle ScholarPubMed
17
Frank, GK, Shott, ME, Hagman, JO, et al. Alterations in brain structures related to taste reward circuitry in ill and recovered anorexia nervosa and in bulimia nervosa. Am J Pschiatry2013; 170:1152–60.Google ScholarPubMed
18
Plassmann, H, O’Douherty, JP, Rangel, A. Appetitive and aversive goal values are encoded in the medical orbitofrontal cortex at the time of decision making. J Neurosci2010; 30:10799–808.CrossRefGoogle Scholar
19
Uher, R, Murphy, T, Brammer, MJ, et al. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry2004; 161:1238–46.CrossRefGoogle ScholarPubMed
20
Frank, GK, Reynolds, JR, Shott, ME, et al. Altered temporal difference learning in bulimia nervosa. Biol Psychiatry2011; 37: 2031–46.Google Scholar
21
Devue, C, Collette, F, Balteau, E, et al. Here I am: the cortical correlates of visual self-regulation. Brain Res2007 Apr 27; 1143:169–82. Epub 2007 Jan 25.CrossRefGoogle Scholar
22
Critchley, HD, Wiens, S, Rotshtein, P, et al. Neural systems supporting interoceptive awareness. Nat Neurosci2004; 7:189–95.CrossRefGoogle ScholarPubMed
23
Konstantakopoulos, G, Varsou, E, Dileos, D, et al. Delusionality of body image beliefs in eating disorders. Psychiatry Res2012; 200:482–8.CrossRefGoogle ScholarPubMed
24
Craig, AD. How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci2009; 10:59–70.CrossRefGoogle Scholar
25
Kothari, R, Gafton, J, Treasure, J, et al. 2D:4D ratio in children at familial high-risk for eating disorders: The role of prenatal testosterone exposure. Am J Hum Biol2014 Mar–Apr; 26(2):176–82. doi:10.1002/ajhb.22495. Epub 2013 Dec 10.CrossRefGoogle Scholar
26
Powers, PS, Santana, CA. Eating disorders: a guide for the primary care physician. Primary Care2002; 29: 81–98.CrossRefGoogle ScholarPubMed
27
Glorio, R, Allevato, M, Pablo, A, et al. Prevalence of cutaneous manifestations of eating disorders in 200 patients with eating disorders. Int J Dermatol2000; 39:348.CrossRefGoogle ScholarPubMed
Titova, OE, Hjorth, OC,Schioth, HB, et al. Anorexia nervosa is linked to reduced brain structure in reward and somatosensory regions: a meta-analysis of VBM studies. BMC Psychiatry2013; 13:110.CrossRefGoogle ScholarPubMed
30
Goldberg, SJ, Comerci, GD, Feldman, L. Cardiac output and regional myocardial contraction in anorexia nervosa. J Adolesc Health Care1988; 9:15.CrossRefGoogle ScholarPubMed
31
Mehler, PS, Winkelman, AB, Andefrson, DM, et al. Nutritional rehabilitation: practical guidelines for refeeding the anorectic patient. J Nutr Metab2010; 2010. pii: 625782. doi: 10.1155/2010/625782. Epub 2010 Feb 7.CrossRefGoogle Scholar
32
Miller, KK, Grinspoon, SK, Ciampa, J, et al. Medical findings in outpatients with anorexia nervosa. Arch Intern Med2005; 165:561.CrossRefGoogle ScholarPubMed
33
Shamim, T, Golden, NH, Arden, M, et al. Resolution of vital sign instability: an objective measure of stability in anorexia nervosa. J Adolesc Health2003; 32:73.CrossRefGoogle ScholarPubMed
Misra, M, Miller, KK, Almazan, C, et al. Hormonal and body composition predictors of soluble leptin receptor, leptin and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab2004 Jul; 89(7):3486–95.CrossRefGoogle ScholarPubMed
36
Grinspoon, S, Gulick, T, Askari, H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab1996; 81: 3861–3.Google ScholarPubMed
37
Katz, MG, Vollenhoven, B. The reproductive endocrine consequences of anorexia nervosa. BJOG2000; 107:707.CrossRefGoogle ScholarPubMed
38
Miller, KK, Grinspoon, SK, Ciampa, J, et al. Medical findings in outpatients with anorexia nervosa. Arch Intern Med2005; 165:561.CrossRefGoogle ScholarPubMed
39
Grinspoon, S, Thomas, E, pitts, S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med2000; 133:790.CrossRefGoogle ScholarPubMed
40
Mehler, PS, Mackenzie, TD. Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature. Int J Eat Disord2009; 42:195.CrossRefGoogle ScholarPubMed
41
Mirsa, M, Prabhakaran, R, Miller, KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab2008; 93(4):1231–7.Google Scholar
42
Birmingham, CL, Alothman, AF, Goldner, EM. Anorexia nervosa: refeeding and hypophosphatemia. Int J Eat Disord1996; 20:211–13.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
43
American Psychiatric Association. Treatment of patients with eating disorders, third edition. American Psychiatric Association. Am J Psychiatry2006; 163(7 Suppl):4–54.Google Scholar
44
Sullivan, PF. Mortality in anorexia nervosa. Am J Psychiatry1995; 152:1073–4.Google ScholarPubMed
45
Sundgot-Borgen, J, Torstveit, MK. Prevalence of eating disorders in elite athletes is higher than in the general population. Clin J Sport Med2004; 14:25–32.CrossRefGoogle ScholarPubMed
46
Morgan, JF, Reid, F, Lacey, JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ1999; 319:639–55.CrossRefGoogle ScholarPubMed
47
Borzekowski, DL, Schenk, S, Wilson, J, et al. e-Ana and e-Mia: a content analysis of pro-eating disorder web sites. Am J Public Health2010; 100:1526–34.CrossRefGoogle ScholarPubMed
48
Halmi, KA. Perplexities of treatment resistance in eating disorders. BMC Psychiatry2013; 13:292.CrossRefGoogle ScholarPubMed
49
Claudino, AM, Silva de Lima, M, Hay, PPJ, et al. Antidepressants for anorexia nervosa. Cochrane Database Syst Rev2006; 1:CD004365.Google Scholar
50
Walsh, BT, Kaplan, AS, Attia, E, et al. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA2006; 295:2605–12.CrossRefGoogle ScholarPubMed
51
Fisher, CA, Hetrick, SE, Rushford, N. Family therapy for anorexia nervosa. Cochrane Database Syst Rev2010; 4:CD004780.Google Scholar
52
Zucker, NL, Marcus, M, Bulik, C. A group parent-training program: a novel approach for eating disorder management. Eat Weight Disord2006;11:327–30.CrossRefGoogle Scholar
53
Hay, PPJ, Bacaltchuk, J, Kashyap, P. Psychological treatments for bulimia nervosa and binging. Cochrane Database Syst Rev2009; 4:CD000562.Google Scholar
54
Bacaltchuk, J, Hay, P. Antidepressants vs. placebo for people with bulimia nervosa. Cochrane Database Syst Rev2003; 4:CD003391.Google Scholar
References
1
US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health and Objectives for Improving Health, 2nd ed. Washington, DC: US Government Printing Office; 2000.Google Scholar
2
US Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent and Decrease Overweight and Obesity. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.Google Scholar
3
US Department of Health and Human ServicesThe Surgeon General’s Vision for a Healthy and Fit Nation. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2010.Google Scholar
Ogden, CL, Carroll, MD, Kit, BK, Flegal, KM. Prevalence of obesity among adults: United States, 2011–2012. NCHS Data Brief No. 131. Hyattsville, MD: National Center for Health Statistics; 2013. Available at: www.cdc.gov/nchs/data/databriefs/db131.pdf. Retrieved July 24, 2014.Google Scholar
6
Flegal, KM, Carroll, MD, Kit, BK, Ogden, CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA.2012; 307: 491–7.CrossRefGoogle ScholarPubMed
7
Ogden, CL, Lamb, MM, Carroll, MD, Flegal, KM. Obesity and socioecomonic status in adults: United States 2005–2008. NCHS Data Brief No. 50. Hyattsville, MD: National Center for Health Statistics; 2010. Available at: www.cdc.gov/nchs/data/databriefs/db50.pdf. Retrieved July 5, 2014.Google Scholar
Finkelstein, EA, Khavjou, OA, Thompson, H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med.2012; 42:563–70.CrossRefGoogle ScholarPubMed
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. Available at: www.nhlbi.nih.gov/guidelines/obesity/ob_galns.htm. Retrieved July 5, 2014.Google Scholar
American College of Obstetricians and Gynecologists. Challenges for overweight and obese women. Committee Opinion No. 591. Obstet Gynecol2014; 123:726–30.Google Scholar
15
Peterson, ND, Middleton, KR, Nackers, LM, et al. Dietaryself-monitoring and long-term success with weight management. Obesity (SilverSpring)2014 Jun 13. doi: 10.1002/oby.20807. [Epub ahead of print] PubMed PMID: 24931055.CrossRefGoogle Scholar
16
Kim, JW, Lin, JE, Blomain, ES, Waldman, SA. Antiobesity pharmacotherapy: new drugs and emerging targets. Clinical Pharmacology & Therapeutics. 2014 Jan; 95(1):53–66.CrossRefGoogle ScholarPubMed
17
Kazemipoor, M, Radzi, C, Hajifaraji, M, et al. Antiobesity effect of caraway extract on overweight and obese women: a randomized, triple-blind, placebo-controlled clinical trial. Evidence-Base Complementary and Alternative Medicine2013; 2013:1–8.CrossRefGoogle ScholarPubMed
18
American College of Obstetricians and Gynecologists. Obesity and pregnancy. Committee Opinion No. 549. Obstet Gynecol.2013 Jan; 121(1):213–17.Google Scholar
19
American College of Obstetricians and Gynecologists. Bariatric surgery and pregnancy. Practice Bulletin No. 105. Obstet Gyencol2009; 113:1405–13.Google Scholar
20
Institute of Medicine of the National Acadamies. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009.Google Scholar
21
Agha, M, Agha, R, Sandell, J. Interventions to reduce and prevent obesity in pre-conceptual and pregnant women: a systematic review and meta-analysis. PLOS one.2014 May; 9(5):e95132.CrossRefGoogle ScholarPubMed
22
Kominiarek, MA, Vanveldhuisen, P, Hibbard, J, et al. The maternal body mass index: a strong association with delivery route: Consortium of Safe Labor. Am J Obstet Gynecol2010; 203(264):E1–7.CrossRefGoogle Scholar
23
Subramaniam, A, Jauk, VC, Goss, AR, et al. Mode of delivery in women with class III obesity: planned cesarean compared to induction of labor. American J of Obstet and Gynecol.2014; doi: 10.1016/j.ajog.2014.06.045.CrossRefGoogle Scholar
24
Kaska, L, Kobiela, J, Abacjeq-Chmylko, A, et al. Nutrition and pregnancy after bariatric surgery. ISRN Obesity.2013 Jan 30; 2013:492060. doi: 10.1155/2013/492060. eCollection 2013.CrossRefGoogle ScholarPubMed
25
Mechanick, JI, Kushner, RF, Sugerman, HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis2008; 4:S109–84.CrossRefGoogle Scholar
26
Galazis, N, Docheva, N, Simillis, C, Nicolaides, K. Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology.2014 July; 181:45–53.CrossRefGoogle ScholarPubMed
27
Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep.2010; 59:1–86.Google Scholar
28
Lopez, LM, Grimes, DA, Chen-Mok, M, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev2010; 7:CD008452.Google Scholar
29
McNicholas, C, Zhao, Q, Secura, G, et al. Contraceptive failures in overweight and obese combined hormonal contraceptive users. Obstet Gynecol2013; 121:585–92.CrossRefGoogle ScholarPubMed
Abdollahi, M, Cushman, M, Rosendaal, F. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost.2003; 89:493–8.CrossRefGoogle ScholarPubMed
32
Mehri, ZO, Impact of bariatric surgery on female reproduction. Fertil Steril.2009; 92:1501–8.Google Scholar
33
Paulen, ME, Zapata, LB, Cansino, C, et al. Contraceptive use among women with a history of bariatric surgery: a systematic review. Contraception.2010; 82:86–94.CrossRefGoogle ScholarPubMed
34
Simkin-Silverman, LR, Wing, RR. Weight gain during menopause. Is it inevitable or can it be prevented?Postgrad Med.2000; 108:47–50, 53–56.CrossRefGoogle ScholarPubMed
35
Davis, SR, Castelo-Branco, C, Chedraui, P, et al. Understanding weight gain at menopause. Climacteric.2012; 15:419–29.CrossRefGoogle ScholarPubMed
36
Huang, AJ, Subak, LL, Wing, R, et al. An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med.2010; 170:1161–7.CrossRefGoogle ScholarPubMed
37
Imayama, I, Alfano, CM, Kong, A, et al. Dietary weight loss and exercise interventions effects on quality of life in overweight/obese postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act.2011; 8:118.CrossRefGoogle ScholarPubMed
38
Norman, RJ, Flight, IH, Rees, MC. Oestrogen and progesterone hormone replacement therapy for peri-menopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst Rev.2000; 2:CD001018.Google Scholar
American College of Obstetricians and Gynecologists. Ethical issues in the care of the obese woman. Committee Opinion No. 600. Obstet Gynecol.2014; 123:1388–93.Google Scholar
US Department of Health and Human Services. The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.Google Scholar
3
Fiore, MC, Jaen, CR, Baker, TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. Available at: www.surgeongeneral.gov/tobacco/index.html. Accessed Sept 14, 2015.Google Scholar
4
Maciosek, MV, Coffield, AB, Edwards, NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med2006;31:52–61.CrossRefGoogle ScholarPubMed
5
Vital signs: current cigarette smoking among adults aged ≥18 years – United States, 2005–2010. MMWR Morb Mortal Wkly Rep.2011 Sep 9;60(35):1207–1212.Google Scholar
6
Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults-United States, 2011. Morb Mortal Wkly Rep2012;61(44):889.Google Scholar
Quinn, VP, Stevens, VJ, Hollis, JF, et al. Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med2005;29:77–84.CrossRefGoogle ScholarPubMed
9
Solberg, LI, Boyle, RG, Davidson, G, et al. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clin Proc2001;76:138–143.CrossRefGoogle ScholarPubMed
10
Barzilai, DA, Goodwin, MA, Zyzanski, SJ, et al. Does health habit counseling affect patient satisfaction?Prev Med2001;33:595–599.CrossRefGoogle ScholarPubMed
11
Weaver, KE, Danhauer, SC, Tooze, JA, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist2012;17(3):455–462. doi: 10.1634/theoncologist.2011-0350. Epub 2012 Feb 14.CrossRefGoogle ScholarPubMed
12
DiClemente, CC, Prochaska, JO, Fairhurst, SK, et al. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology1991 Apr;59(2):295–304. http://dx.doi.org/10.1037/0022-006X.59.2.295.CrossRefGoogle ScholarPubMed
13
Goldberg, DN, Hoffman, AM, Farinha, MF, et al. Physician delivery of smoking-cessation advice based on the stages-of-change model. American Journal of Preventive Medicine1994 Sep–Oct;10(5):267–274.CrossRefGoogle ScholarPubMed
14
Norcross, JC, Krebs, PM, Prochaska, JO. Stages of change. Journal of Clinical Psychology, Special Issue: Adapting psychotherapy to the individual patient. 2011 Feb;67(2):143–154.CrossRefGoogle ScholarPubMed
Rundmo, T, Smedslund, G, Gotestam, KG. Motivation for smoking cessation among the Norwegian public. Addict Behav1997;22:377–386.CrossRefGoogle ScholarPubMed
17
Alberg, AJ, Carter, CL, Carpenter, MJ. Weight gain as an impediment to cigarette smoking cessation: a lingering problem in need of solutions. Prev Med2007;44:296–297.CrossRefGoogle ScholarPubMed
18
Donze, J, Ruffieux, C, Cornuz, J. Determinants of smoking and cessation in older women. Age Ageing2007;36:53–57.CrossRefGoogle ScholarPubMed
19
Fagan, P, Augustson, E, Backinger, CL, et al. Quit attempts and intention to quit cigarette smoking among young adults in the United States. Am J Public Health2007;97:1412–1420.CrossRefGoogle ScholarPubMed
20
Chan, SS, Lam, TH, Salili, F, et al. A randomized controlled trial of an individualized motivational intervention on smoking cessation for parents of sick children: a pilot study. Appl Nurs Res2005;18:178–181.CrossRefGoogle ScholarPubMed
21
Butler, CC, Rollnick, S, Cohen, D, et al. Motivational consulting versus brief advice for smokers in general practice: a randomized trial. Br J Gen Pract1999;49:611–616.Google Scholar
22
Curry, SJ, Ludman, EJ, Graham, E, et al. Pediatric-based smoking cessation intervention for low-income women: a randomized trial. Arch Pediatr Adolesc Med2003;157:295–302.CrossRefGoogle ScholarPubMed
23
Brown, RA, Ramsey, SE, Strong, DR, et al. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tob Control2003;12(Suppl 4):IV3–10.CrossRefGoogle ScholarPubMed
24
Steinberg, ML, Ziedonis, DM, Krejci, JA, et al. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol2004;72:723–728.CrossRefGoogle ScholarPubMed
25
Lai, DTC, Cahill, K, Qin, Y, Tang, JL. Motivational interviewing for smoking cessation. Cochrane Database Syst Revs2010;1:CD006936. doi: 10.1002/14651858.CD006936.pub2.Google Scholar
Ahluwalia, JS, Okuyemi, K, Nollen, N, et al. The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial design. Addiction2006;101:883–891.CrossRefGoogle ScholarPubMed
28
Carpenter, MJ, Hughes, JR, Solomon, LJ, et al. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol2004;72:371–381.CrossRefGoogle ScholarPubMed
29
Amrhein, PC, Miller, WR, Yahne, CE, et al. Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol2003;71:862–878.CrossRefGoogle ScholarPubMed
30
Rollnick, S, Miller, WR, Butler, CC. Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York: The Guilford Press, 2008.Google Scholar
31
Miller, WR, Rollnick, S. Motivational Interviewing: Preparing People for Change, 2nd ed. New York: Guilford Press, 2002.Google Scholar
32
Rollnick, S, Mason, P, Butler, C. Health Behavior Change: A Guide for Practitioners.Edinburgh: Churchill Livingstone, 1999.Google Scholar
33
Carpenter, MJ, Hughes, JR, Solomon, LJ. et al. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol2004;72:371–381.CrossRefGoogle ScholarPubMed
34
Carpenter, MJ, Hughes, JR, Keely, JP. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res2003;5:155–162.CrossRefGoogle ScholarPubMed
35
Atkinson, AL, Sherlock, D. Is smoking cessation counselling effective in the OB/GYN office? A prospective study. International Journal of Medical Science and Public Health2013;2(3):558–561.CrossRefGoogle Scholar
36
Godtfredsen, NS, Hoist, C, Prescott, E, et al. Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from the Copenhagen Centre for Prospective Population Studies. Am J Epidemiol2002 Dec 1;156(11):994–1001.CrossRefGoogle Scholar
37
Bolliger, CT, Zellweger, JP, Danielsson, T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ2000 Aug 5;321(7257):329–333.CrossRefGoogle ScholarPubMed
Lancaster, T, Stead, L, Silagy, C, Sowden, A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ2000 Aug 5;321(7257):355–358.CrossRefGoogle ScholarPubMed
40
Stead, LF, Lancaster, T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev2012;12:CD009670. doi: 10.1002/14651858.CD009670.pub2.Google ScholarPubMed
Bullen, C, Howe, C, Laugesen, M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet2013;382(9905):1629–1637.CrossRefGoogle ScholarPubMed
56
Zhu, S, Melcer, T, Sun, J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med2000;18:305–311.CrossRefGoogle ScholarPubMed
57
Munafo, M, Bradburn, M, Bowes, L, et al. Are there sex differences in transdermal nicotine replacement therapy patch efficacy?A meta-analysis. Nicotine Tob Res2004;6:769–776.Google ScholarPubMed
58
Smith, SS, Jorenby, DE, Leischow, SJ, et al. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res2003;5:99–109.CrossRefGoogle ScholarPubMed
59
Jarvis, MJ, Cohen, JE, Delneo, CD, Giovino, GA. Dispelling myths about gender differences in smoking cessation: population data from the USA, Canada and Britain. Tobacco Control2013 Sep;22(5):356–360.CrossRefGoogle ScholarPubMed
60
Husky, MM, Mazure, CM, Paliwal, P, McKee, SA. Gender differences in the comorbidity of smoking behavior and major depression. Drug and Alcohol Dependence2008 Jan 11;93(1–2):176–179.CrossRefGoogle ScholarPubMed
61
Farley, AC, Hajek, P, Lycett, D, Aveyard, P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev2012;1:CD006219. doi: 10.1002/14651858.CD006219.pub3.Google ScholarPubMed
62
Armour, BS, Campbell, VA, Crews, JE, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med2007 Oct;33(4):297–305.Google Scholar
63
U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2006. Available at: www.surgeongeneral.gov/library/reports/secondhandsmoke/fullreport.pdf. Accessed Dec 21, 2015.Google Scholar
64
American College of Obstetricians and Gynecologists. Smoking cessation during pregnancy. Obstet Gynecol2005;106:883–888.CrossRefGoogle Scholar
65
England, LJ, Kendrick, JS, Wilson, HG, et al. Effects of smoking reduction during pregnancy on the birth weight of term infants. Am J Epidemiol2001;154:694–701.CrossRefGoogle ScholarPubMed
66
Lieberman, E, Gremy, I, Lang, JM, et al. Low birthweight at term and the timing of fetal exposure to maternal smoking. Am J Public Health1994 Jul;84(7):1127–1131.CrossRefGoogle ScholarPubMed
67
DiClemente, CC, Dolan-Mullen, P, Windsor, RA. The process of pregnancy smoking cessation: implications for interventions. Tob Control2000;9(Suppl 3):III16–III21.CrossRefGoogle ScholarPubMed
References
1
Viniol, A, Keunecke, C, Biroga, T, et al. Studies of the symptom abdominal pain – a systematic review and meta-analysis. Family Practice2014; 0: 1–13.Google Scholar
2
Worly, B, Schlaff, W. Endometriosis and chronic pelvic pain. Postgraduate Obstetrics & Gynecology2012; 18: 1–7.Google Scholar
3
McPhee, M, Lingappa, V, Ganong, W. Pathophysiology of Disease: An Introduction to Clinical Medicine, Fourth Edition. New York: Lange Medical Books/McGraw-Hill Medical Publishing Division, 2003.Google Scholar
4
Bickley, L, Szilagyi, P. Bates Guide to Physical Examination and History Taking, Eleventh Edition. New York: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2013.Google Scholar
5
Netter, F. Atlas of Human Anatomy, Second Edition. Canada: Friesens Corporation, 1997.Google Scholar
6
Worly, B, Schlaff, W. Chronic pelvic pain unrelated to endometriosis. Postgraduate Obstetrics & Gynecology2012; 19: 1–7.Google Scholar
7
Trinkley, K, Nahata, M. Medication management of irritable bowel syndrome. Digestion2014; 89: 253–267.CrossRefGoogle ScholarPubMed
8
Vennix, S, Morton, D, Hahnloser, D, et al. Systematic review of evidence and consensus on diverticulitis: an analysis of national and international guidelines. Colorectal Dis2014 Nov; 16(11): 866–878.CrossRefGoogle ScholarPubMed
9
Effective Health Care Program. Surgical management of inguinal hernia. Agency for Healthcare Research and Quality2013; 12: 1–3.Google Scholar
10
Pearle, M, Goldfarb, D, Assimos, D, et al. Medical management of kidney stones: AUA guideline. Journal of Urology2014; 192: 316–324.CrossRefGoogle ScholarPubMed
11
Dyer, A, Twiss, C. Painful bladder syndrome: an update and review of current management strategies. Current Urology Reports2014; 384: 1–10.Google Scholar
Doubilet, P, Benson, C, Bourne, T, Blaivas, M. Diagnostic criteria for nonviable pregnancy early in the first trimester. New England Journal of Medicine2013; 369: 1443–1451.CrossRefGoogle ScholarPubMed
14
Mitchell, C, Prabhu, M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infectious Disease Clinics of North America2013; 27: 793–809.CrossRefGoogle ScholarPubMed
Khan, A, Shehmar, M, Gupta, J. Uterine fibroids: current perspectives. International Journal of Women’s Health2014; 6: 95–114.CrossRefGoogle ScholarPubMed
18
Levy, G, Dehaene, A, Laurent, N, Lernout, M. An update on adenomyosis. Diagnostic and Interventional Imaging2013; 94: 3–25.CrossRefGoogle ScholarPubMed
19
Berman, M, Randall-Whitis, L. Management of adnexal masses. ACOG Practice Bulletin2007; 83: 1–14.Google Scholar
National Center for Health Statistics. Health, United States, 2012: With Special Feature on Emergency Care. Hyattsville: US Government Printing Office; 2013.Google Scholar
2
Doumas, M, Papademetriou, V, Faselis, C, Kokkinos, P. Gender differences in hypertension: myths and reality. Curr Hypertens Rep.2013;15(4):321–30.CrossRefGoogle Scholar
3
Lima, R, Wofford, M, Reckelhoff, JF. Hypertension in postmenopausal women. Curr Hypertens Rep.2012;14(3):254–60.CrossRefGoogle ScholarPubMed
4
Laz, TH, Rahman, M, Berenson, AB. Trends in serum lipids and hypertension prevalence among non-pregnant reproductive-age women: United States National Health and Nutrition Examination Survey 1999–2008. Matern Child Health J.2013;17:1424–31.CrossRefGoogle ScholarPubMed
5
National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda: NHLBI Health Information Center; 2004.Google Scholar
6
Hage, FG, Mansur, SJ, Xing, D, Oparil, S. Hypertension in women. Kidney Int Suppl (2011). 2013;3(4):352–6.Google ScholarPubMed
7
James, PA, Oparil, S, Carter, BL, Cushman, WC, Dennison-Himmelfarb, C, Handler, J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.CrossRefGoogle Scholar
8
Mancia, G, Fagard, R, Narkiewicz, K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens.2013;31(7):1281–357.CrossRefGoogle ScholarPubMed
9
Kleman, M, Dhanyamraju, S, DiFillipo, W. Prevalence and characteristics of pseudohypertension in patients with “resistant hypertension.”J Am Soc Hypertens.2013;7(6):467–70.CrossRefGoogle ScholarPubMed
10
Lipsitz, LA. A 91 year-old woman with difficult-to-control hypertension. JAMA. 2013;310(12):1274–80.CrossRefGoogle ScholarPubMed
11
Franklin, SS, Thijs, L, Hansen, TW, et al. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–7.CrossRefGoogle ScholarPubMed
12
Abramson, BL, Melvin, RG. Cardiovascular risk in women: focus on hypertension. Can J Cardiol.2014;30(5):553–9.CrossRefGoogle ScholarPubMed
13
Ha, SK. Dietary salt intake and hypertension. Electrolyte Blood Press. 2014;12(1):7–18.CrossRefGoogle ScholarPubMed
14
Song, HJ, Paek, YJ, Choi, MK, Lee, HJ. Gender differences in the relationship between risk of hypertension and fruit intake. Prev Med.2014;67(C):154–9.CrossRefGoogle ScholarPubMed
15
Laouis, M, Bijon, A, Fagherazzi, G, et al. Processed and unprocessed red meat consumption and hypertension in women. Am J Clin Nutr.2014 Sep;100(3):948–52. doi: 10/3945/ajcn.113.080598. Epub 2014 Jul 30.Google Scholar
16
Huai, P, Xun, H, Reilly, KH, et al. Physical activity and risk of hypertension: a meta-analysis of prospective cohort studies. Hypertension. 2013;62(6):1021–6.CrossRefGoogle ScholarPubMed
17
Gangwisch, JE, Feskanich, D, Malaspina, D, et al. Sleep duration and risk for hypertension in women: results from the Nurses’ Health Study. Am J Hypertens.2013;26(7):903–11.CrossRefGoogle ScholarPubMed
18
Griffin, FC, Gadegbeku, CA, Sowers, MS. Vitamin D and subsequent systolic hypertension among women. Am J Hypertens.2011;24(3):316–21.CrossRefGoogle ScholarPubMed
19
Varenna, M, Manara, M, Galli, L, et al. The association between osteoporosis and hypertension: the role of a low dairy intake. Calcif Tissue Int.2013;93(1):86–92.CrossRefGoogle ScholarPubMed
20
Chen, H, Nembhard, WN, Stockwell, HG. Sex-specific effects of fetal exposure to the 1959–61 Chinese famine on risk of adult hypertension. Matern Child Health J.2014;18(3):527–33.CrossRefGoogle Scholar
21
Wakabayashi, I. Stronger associations of obesity with prehypertension and hypertension in young women than in young men. J Hypertens.2012;30(7):1423–9.CrossRefGoogle ScholarPubMed
22
Sirmans, S, Pate, K. Epidemiology, diagnosis, and management of polycystic ovarian syndrome. Clin Epidemiol.2014;6:1–13.Google Scholar
23
Park, H, Kim, K. Associations between oral contraceptive use and risk of hypertension and prehypertension in a cross-sectional study of Korean women. BMC Women’s Health. 2013;13:39.CrossRefGoogle Scholar
He, FJ, Li, J, MacGregor, GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev.2013;4:CD004937.Google Scholar
26
Lotenberg, LD, Clough, LC, Mackey, TA, et al. Lessons learned from a survey of the diagnosis and treatment of journeys of postmenopausal women with hypertension. J Clin Hypertens.2013;15(8):532–41.Google Scholar
27
Chappell, LC, Enye, S, Seed, P, et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension. Hypertension. 2008;51(4):1002–9.CrossRefGoogle ScholarPubMed
28
Weng, LC, Steffen, LM, Szklo, M, et al. A diet pattern with more dairy and nuts, but less meat is related to lower risk of developing hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Nutrients. 2013;5(5):1719–33.CrossRefGoogle ScholarPubMed
29
Frank, JE, Sommerfeld, D. Clinical approach in treatment of resistant hypertension. Integrated Blood Pressure Control. 2009;2:9–23.CrossRefGoogle ScholarPubMed
Mosca, L, Ferris, A, Fabunmi, R, Robertson, RM. Tracking women’s awareness of heart disease: An American Heart Association National Study. Circulation. Available at: www.circulationha.org. DOI: 10.1161/01.CIR.0000115222.69428.C92004; Feb 4; 573–579. (Accessed Nov. 17, 2014.)CrossRefGoogle Scholar
2
Mosca, L, Linfante, AH, Benjamin, EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. Available at: www.circulationha.org. DOI: 10.1161/01.CIR0000154568.43333.822005; 111: 499–510. (Accessed Nov. 17, 2014.)CrossRefGoogle ScholarPubMed
3
Abuful, A, Gidron, Y, Henkin, Y. Physicians’ attitudes toward preventive therapy for coronary artery disease: Is there a gender bias?Clin Cardiol2005 Aug;28: 389–393.CrossRefGoogle Scholar
4
Rosamond, W, Flegal, K, Furie, K, et al. (Writing group). Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. Available at: http://circ.ahajournals.org. DOI: 10.1161/CIRCULATIONAHA.107.187998. 2008; 117: e25–e146. (Accessed Nov. 17, 2014.)Google ScholarPubMed
5
Kim, AM, Tingen, CM, Woodruff, TK. Sex bias in trials and treatment must end. Nature2010 June 10; 465: 688–689.CrossRefGoogle ScholarPubMed
6
Mosca, L, Benjamin, EJ, Berra, K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 Update: A guideline from the American Heart Association. J Am Coll Cardiol2011 Mar 22; 57(12): 1404–1423. DOI:10.1016/j.jacc.2011.02.005.CrossRefGoogle ScholarPubMed
Gotto, AM, Moon, JE. Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol2012; 110(suppl): 3A–14A.CrossRefGoogle ScholarPubMed
9
Wenger, NK. Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association guidelines. Adv Chronic Kidney Dis2013 Sep; 20(5): 419–422.CrossRefGoogle ScholarPubMed
10
Puurunen, J, Piltonen, T, Puukka, K, et al. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab2013 Dec; 98(12): 4798–4807.CrossRefGoogle ScholarPubMed
11
Spracklen, CN, Smith, CJ, Saftlas, AF, et al. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol2014 Aug; 180(4): 346–358.CrossRefGoogle ScholarPubMed
12
Mosca, L, Benjamin, EJ, Berra, K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011update: a guideline from the American Heart Association. Circulation2011; 123(11): 1243–1262.CrossRefGoogle ScholarPubMed
13
Roberts, JM, August, PA, Bakris, G, et al. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ task force in hypertension in pregnancy. Obstet Gynecol2013 Nov; 122(5): 1122–1131.Google Scholar
Daniels, SR, Greer, FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics2008; 122: 198–208.CrossRefGoogle ScholarPubMed
18
National Institute for Health and Care Excellence. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE Clinical Guideline 1812014 July; 1–50.Google Scholar
19
Jellinger, PS, Smith, DA, Mehta, AE, et al. American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract2012; 18(suppl 1): 1–77.CrossRefGoogle Scholar
20
Stone, NJ, Robinson, J, Lichtenstein, AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation2013 Nov. Available at: http://circ.ahajournals.org/content/early2013/11/11/11/01.cir.0000437738.63852.7a. citation. (Accessed May 15, 2015.)Google Scholar
21
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Contraception1998; 57: 315–324.CrossRefGoogle Scholar
22
Kemmeren, JM, Tanis, BC, van den Bosch, MAAJ, et al. Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke2002; 33: 1202–1208.CrossRefGoogle ScholarPubMed
23
Tanis, BC, van den Bosch, MAAJ, Kemmeren, JM, et al. Oral Contraceptives and the risk of myocardial infarction. N Engl J Med2001 Dec; 345(25): 1787–1793.CrossRefGoogle ScholarPubMed